Publications

5808 Results

Mitotic counts in follicular lymphomas.

Authors
DJ Ellison;BN Nathwani;GE Metter;RR Turner;JS Burke;TP Miller;RB Mann;M Barcos;CR Kjeldsberg;CD Winberg;CC Whitcomb
Journal / Conference
Human Pathology 18:502-505
Year
1987
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-7426/7427, SWOG-7713/14

Cardiotoxicity in patients treated with mitoxantrone: Southwest Oncology Group phase II studies.

Authors
FJ Mather;RM Simon;DD Von Hoff
Journal / Conference
Cancer Treat Rep 71(6):
Year
1987
Research Committee(s)
Breast, Genitourinary, and Lymphoma
Study Number(s)
SWOG-8203/04, SWOG-8517

Chemotherapy alone versus combined modality therapy for stage IIIhodgkin's disease: a five-year follow-up of a Southwest OncologyGroup study.

Journal / Conference
Third International Conference on Malignant Lymphoma-Lugano June 10-13
Year
1987
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-7518

SWOG-8024: Combined modality therapy for disseminated softtissue sarcoma, phase III.

Authors
L Baker;S Green;J Ryan;B Rosenberg;S Balcerzak
Journal / Conference
ASCO :#C-542
Year
1987
Research Committee(s)
Sarcoma
Study Number(s)
SWOG-8024

Alternated and syncopated CHOP-CVB. A test of the Goldie-Coldmanhypothesis by the Southwest Oncology Group.

Authors
L Dabich;MK Liepman;AF LoBuglio;BK Schnitzer;S Dahlberg;PN Grozea;JW Athens;RP Pugh
Journal / Conference
ASCO :#C-810
Year
1987
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8112

Southwest Oncology Group (SWOG) trial: VM-26 and ifosfamide (IF)in refractory adult lymphocytic leukemia (ALL).

Authors
DH Ryan;KJ Kopecky;CH Gumbart;JN Bickers
Journal / Conference
ASCO :#C-561
Year
1987
Research Committee(s)
Leukemia
Study Number(s)
SWOG-8243

Concurrent chemoradiotherapy for limited small cell carcinoma ofthe lung (SCCL).

Authors
JD McCracken;L Janaki;SA Taylor;GB Weiss;J Crowley
Journal / Conference
ASCO :#C-656
Year
1987
Research Committee(s)
Lung
Study Number(s)
SWOG-8269

Concommitant chemo radiotherapy in limited small cell carcinomaof lung: Improved response and median survival. A Southwest OncologyGroup Study.

Authors
LM Janaki;JD McCracken;SB Taylor;PGS Giri;GB Weiss;W Gordon, Jr;RB Vance;J Crowley
Journal / Conference
Presented at the 29th Annual ASTRO Meeting in Boston October 18-23
Year
1987
Research Committee(s)
Lung
Study Number(s)
SWOG-8269

A randomized intergroup trial of adjuvant doxorubicin (DOX) for soft tissue sarcomas (STS): Lack of apparent difference between treatment groups.

Authors
K Antman;D Amato;M Pilepich;H Lerner;S Balcerzak;E Borden;L Baker
Journal / Conference
ASCO 6:134(525)
Year
1987
Research Committee(s)
Sarcoma
Study Number(s)
SWOG-8291, SWOG-8391

Toxicity and hematopoietic reserve following hemibodyirradiation (HBI) and CHOP chemotherapy for non-hodgkin's lymphoma(NHL).

Authors
KM Sullivan;PE Neiman;S Dahlberg;R Rivkin;D Tesh
Journal / Conference
ASCO :#C-770
Year
1987
Research Committee(s)
Lymphoma
Study Number(s)
SWOG-8361